NASDAQ:CERN - Cerner Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$54.97 +0.53 (+0.97 %)
(As of 12/11/2018 04:00 PM ET)
Previous Close$54.44
Today's Range$54.26 - $55.36
52-Week Range$50.91 - $73.43
Volume3.42 million shs
Average Volume2.20 million shs
Market Capitalization$17.70 billion
P/E Ratio24.99
Dividend YieldN/A
Beta0.96
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware, that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:CERN
Previous Symbol
CUSIP15678210
Phone816-221-1024

Debt

Debt-to-Equity Ratio0.09
Current Ratio2.63
Quick Ratio2.60

Price-To-Earnings

Trailing P/E Ratio24.99
Forward P/E Ratio24.76
P/E Growth1.76

Sales & Book Value

Annual Sales$5.14 billion
Price / Sales3.52
Cash Flow$4.0749 per share
Price / Cash Flow13.49
Book Value$14.40 per share
Price / Book3.82

Profitability

EPS (Most Recent Fiscal Year)$2.20
Net Income$866.97 million
Net Margins15.72%
Return on Equity14.73%
Return on Assets11.00%

Miscellaneous

Employees26,000
Outstanding Shares329,490,000
Market Cap$17.70 billion
OptionableOptionable

Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner announced that its board has initiated a stock repurchase program on Sunday, June 4th 2017, which allows the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to buy up to 2.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) released its quarterly earnings results on Thursday, October, 25th. The company reported $0.57 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.58 by $0.01. The company had revenue of $1.34 billion for the quarter, compared to analysts' expectations of $1.36 billion. Cerner had a net margin of 15.72% and a return on equity of 14.73%. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner updated its FY 2018 earnings guidance on Thursday, October, 25th. The company provided EPS guidance of $2.46-2.46 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.50. The company issued revenue guidance of $5.396-5.396 billion, compared to the consensus revenue estimate of $5.41 billion.Cerner also updated its Q4 2018 guidance to $0.62-0.64 EPS.

What price target have analysts set for CERN?

18 brokerages have issued 1 year target prices for Cerner's shares. Their forecasts range from $54.00 to $77.00. On average, they anticipate Cerner's share price to reach $69.7906 in the next year. This suggests a possible upside of 26.1% from the stock's current price. View Analyst Price Targets for Cerner.

What is the consensus analysts' recommendation for Cerner?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. According to Zacks Investment Research, "Cerner continues to gain from its Population Health, Revenue Cycle and ITWorks platforms. Solid year-over-year bookings growth is a positive. Gains in Professional and Managed Services units buoy optimism. Management is optimistic about the alliance with Lumeris, signed earlier this year. Continued activity with the Department of Veterans Affairs encourages. A strong fourth-quarter and full-year outlook is heartening. On the flip side, Cerner’s key Licensed Software and Subscriptions revenue segments have been witnessing some sluggishness in recent times. In fact, management expects low Licensed Software bookings to affect total bookings in the quarters to come. Contraction in gross and operating margins adds to the woes. High long-term debt and competition in the global MedTech space raise concern. Cerner underperformed the industry in a year's time." (12/10/2018)
  • 2. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $80. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off (including the potential impact from the VA contract). Valuation Summary Cerner shares trade at a 25% discount to our DCF-based price target of $80 (including the VA contract)." (9/12/2018)

Has Cerner been receiving favorable news coverage?

Media coverage about CERN stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cerner earned a coverage optimism score of 1.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of Cerner's key competitors?

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. Clifford W. Illig, Co-Founder & Vice Chairman (Age 67)
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 63)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 53)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 54)
  • Mr. David Brent Shafer, Chairman & CEO (Age 61)

Who are Cerner's major shareholders?

Cerner's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.88%), BlackRock Inc. (6.36%), Bank of New York Mellon Corp (4.57%), Loomis Sayles & Co. L P (3.98%), Fiduciary Management Inc. WI (1.87%) and Veritas Asset Management LLP (1.36%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Which institutional investors are selling Cerner stock?

CERN stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC, Bristol John W & Co. Inc. NY, FMR LLC, AXA, Mitsubishi UFJ Trust & Banking Corp, Fiduciary Management Inc. WI, Capital Fund Management S.A. and Teachers Advisors LLC. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.

Which institutional investors are buying Cerner stock?

CERN stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, MERIAN GLOBAL INVESTORS UK Ltd, Panagora Asset Management Inc., American Century Companies Inc., Morgan Stanley, Obermeyer Wood Investment Counsel Lllp, Vanguard Group Inc. and Commonwealth Bank of Australia. View Insider Buying and Selling for Cerner.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $55.36.

How big of a company is Cerner?

Cerner has a market capitalization of $17.70 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe.

What is Cerner's official website?

The official website for Cerner is http://www.cerner.com.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]


MarketBeat Community Rating for Cerner (NASDAQ CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  850 (Vote Outperform)
Underperform Votes:  527 (Vote Underperform)
Total Votes:  1,377
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel